Geode Capital Management
XTNT icon

Geode Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Geode Capital Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Buy
529,214
+37,265
+8% +$22.9K ﹤0.01% 3785
2025
Q4 		$386K Hold
491,949
– – ﹤0.01% 3688
2025
Q3 		$319K Sell
491,949
-61,675
-11% -$38.9K ﹤0.01% 3771
2025
Q2 		$409K Buy
553,624
+4,359
+0.8% +$2.48K ﹤0.01% 3620
2025
Q1 		$258K Buy
549,265
+37,390
+7% +$19.7K ﹤0.01% 3762
2024
Q4 		$227K Sell
511,875
-3,131
-0.6% -$1.52K ﹤0.01% 3867
2024
Q3 		$348K Buy
515,006
+212,394
+70% +$140K ﹤0.01% 3717
2024
Q2 		$191K Sell
302,612
-13,546
-4% -$10.8K ﹤0.01% 3925
2024
Q1 		$370K Buy
316,158
+54,253
+21% +$59.5K ﹤0.01% 3719
2023
Q4 		$296K Buy
261,905
+1,401
+0.5% +$1.65K ﹤0.01% 3811
2023
Q3 		$287K Buy
260,504
+236,911
+1,004% +$254K ﹤0.01% 3824
2023
Q2 		$21.9K Hold
23,593
– – ﹤0.01% 4647
2023
Q1 		$15K Hold
23,593
– – ﹤0.01% 4736
2022
Q4 		$15K Hold
23,593
– – ﹤0.01% 4801
2022
Q3 		$16K Hold
23,593
– – ﹤0.01% 4939
2022
Q2 		$12K Buy
23,593
+2,389
+11% +$1.42K ﹤0.01% 4976
2022
Q1 		$14K Hold
21,204
– – ﹤0.01% 4952
2021
Q4 		$11K Hold
21,204
– – ﹤0.01% 4965
2021
Q3 		$23K Hold
21,204
– – ﹤0.01% 4836
2021
Q2 		$34K Hold
21,204
– – ﹤0.01% 4691
2021
Q1 		$50K Buy
+21,204
New +$45.3K ﹤0.01% 4406
2015
Q2 		– Sell
-1,435
Closed -$70K – 3990
2015
Q1 		$70K Hold
1,435
– – ﹤0.01% 3816
2014
Q4 		$52K Hold
1,435
– – ﹤0.01% 3869
2014
Q3 		$77K Buy
1,435
+739
+106% +$49.1K ﹤0.01% 3793
2014
Q2 		$56K Hold
696
– – ﹤0.01% 3770
2014
Q1 		$70K Hold
696
– – ﹤0.01% 3725
2013
Q4 		$41K Hold
696
– – ﹤0.01% 3710
2013
Q3 		$56K Buy
696
+269
+63% +$19.3K ﹤0.01% 3567
2013
Q2 		$23K Buy
+427
New +$35.3K ﹤0.01% 3584

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management's XTNT Position: Q1 2026 in Review

Geode Capital Management increased its Xtant Medical Holdings (XTNT) stake by 7.6% in Q1 2026, buying an estimated $22.9K and bringing the position to 529,214 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #3785.

Geode Capital Management first reported a position in XTNT in Q2 2013 and has held it in 29 quarters since. The position peaked at $409K in Q2 2025. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Geode Capital Management held 529,214 shares of Xtant Medical Holdings worth $295K as of Q1 2026.
  • Geode Capital Management bought 37,265 Xtant Medical Holdings shares in Q1 2026, an estimated $22.9K.
  • Xtant Medical Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3785 holding.
  • Geode Capital Management first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 29 quarters since.
  • Geode Capital Management's Xtant Medical Holdings position peaked at $409K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.